Certain organizations will be able to sell analyses of Medicare data for the first time under a final rule published July 1.
The rule allows organizations specially approved by the Centers for Medicare & Medicaid Services, known as qualified entities, to sell analyses of Medicare Part A, Part B and Part D (facility, physician and prescription drug) claims data, the agency said. Personal health information and underlying claims data must be kept confidential between the organizations collecting them and those acquiring the data, the CMS said in a July 1 statement.
Providers, such as for-profit hospital operator Community Health Systems ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.